Oceania · Markets & Finance · Stockhead

Orthocell nerve repair product Remplir shows promise in prostate cancer surgery

Published by Stockhead · Australia 16 h ago

Results show excellent early functional recovery in clinically complex patients with advanced prostate cancer ... Read More The post Orthocell nerve repair product Remplir shows…

Read the full article on Stockhead Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (stockhead.com.au)

Also worth reading

The Motley Fool Australia

Lithium carnage: Why PLS has halved in four months as peers MinRes, IGO and Liontown tumble

Startup Daily

Orthocell nerve repair product Remplir shows promise in prostate cancer surgery

Share

Also worth reading

3 dirt cheap ASX shares I think are undervalued today

More than 300 scientists say AI oversight needed after 'preventable' hacks

Grin and bear it: the RBA’s hammer can’t hit the big targets

PM personally brokered ATO credit card pause

Lithium carnage: Why PLS has halved in four months as peers MinRes, IGO and Liontown tumble

How this founder took legal tech startup Dispute Buddy from zero to $2 million ARR in just 9 months